|
|
||||||||
Eur J Cardiothorac Surg 2002;21:224-231
© 2002 Elsevier Science NL
a Department of Cardiothoracic Surgery, AKH Wien, Währinger Gürtel 18-20, 1090 Vienna, Austria
b Ludwig Boltzmann Institute for Heart Research, Vienna, Austria
c Department of Histology II, University of Vienna, Vienna, Austria
Received 16 July 2001; received in revised form 12 November 2001; accepted 14 November 2001.
* Corresponding author. Tel.: +43-1-404-005-620; fax: +43-1-404-005-640
e-mail: bruno.podesser{at}akh-wien.ac.at
Objective: This study evaluates the effects of diltiazem administered during reperfusion on hemodynamic, metabolic, and ultrastructural postischemic outcome. Methods: Hearts of 38 adult White New Zealand rabbits underwent 60 min of global cold ischemia followed by 40 min of reperfusion in an erythrocyte perfused isolated working heart model. Hearts were randomly assigned to four groups and received diltiazem (0.1, 0.25, and 0.5 µmol/l) during reperfusion only, or served as control. Results: The postischemic time courses of heart rate, aortic flow, and external stroke work clearly reflected the dose-dependent negative chronotropic and inotropic efficacy of diltiazem in the two higher concentrations. High energy phosphates (HEP) determined from myocardial biopsies taken after 40 min of reperfusion were significantly better preserved in all treatment groups compared to control hearts. Similarly ultrastructural grading of mitochondria and myofilaments revealed a significant reduction of reperfusion injury in hearts that received diltiazem compared to control. Conclusions: Diltiazem protects mitochondrial integrity and function, thereby preserving myocardial HEP levels. Only low dose diltiazem (0.1 µmol/l) during reperfusion combines both, optimal mitochondrial preservation with minimal changes in hemodynamics.
Key Words: Reperfusion Mitochondria Diltiazem Isolated Working heart Rabbit
This article has been cited by other articles:
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |